Soleno Therapeutics

+$0.0118 (+1.29%) Today
-$0.0239 (-2.59%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLNO and other ETFs, options, and stocks.

About SLNO

Soleno Therapeutics, Inc. engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. The firm focuses on the treatment of metabolic and neurobehavioral disorder.

CEO
Anish Bhatnagar
Employees
31
Headquarters
Redwood City, California
Founded
1999

SLNO Key Statistics

Market Cap
73.86M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
430.53K
High Today
$0.9324
Low Today
$0.9011
Open Price
$0.91
Volume
78.51K
52 Week High
$3.36
52 Week Low
$0.80

SLNO Earnings

-$0.36
-$0.24
-$0.12
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure